ATLA 42.6, December 2014

//ATLA 42.6, December 2014

Editorial: The 2013 Lush Prize Awards

Kelly A. BéruBé and Craig Redmond

The Lush Prize is a major initiative, aiming to bring forward the day when safety testing takes place without the use of animals. It focuses on the use of alternatives to animals for the toxicity testing of consumer products and ingredients, in a way that complements the many projects already addressing the use of animals in medical testing.
You need to register (for free) to download this article. Please log in/register here.
2017-01-09T06:03:24+00:00 Tags: |

IIVS News & Views

ATLA Staff Writer

EPAA and IIVS Collaborate to Produce In Vitro Test Method Training Videos
IIVS Presentations at Industry Events
Corrositex® Training Presented in Prague
Predicting Eye Stinging with the Novel NociOcular Assay: Investigating Surfactant, Sunscreen and Ophthalmic Products
Tobacco Science Regulatory Conference
You need to register (for free) to download this article. Please log in/register here.
2017-01-09T06:03:25+00:00 Tags: , |

Human-based Systems in Drug and Chemical Safety Testing — Toward Replacement, the ‘Single R’

Robert A. Coleman

The Three Rs was a concept originally conceived as a means of reducing the suffering of laboratory animals that are used largely in identifying any potential safety issues with chemicals to which humans may be exposed. However, with growing evidence of the shortcomings of laboratory animal testing to reliably predict human responsiveness to such chemicals, questions are now being asked as to whether it is appropriate to use animals as human surrogates at all. This raises the question of whether, of the original Three Rs, two — Reduction and Refinement — are potentially redundant, and whether, instead, we should concentrate on the third R: Replacement. And if this is the best way forward, it is inevitable that this R should be based firmly on human biology. The present review outlines the current state-of-the-art regarding our access to human biology through in vitro, in silico and in vivo technologies, identifying strengths, weaknesses and opportunities, and goes on to address the prospect of achieving a single R, with some suggestions as to how to progress toward this goal.
You need to register (for free) to download this article. Please log in/register here.

Development of an In Silico Profiler for Respiratory Sensitisation

Steven J. Enoch, David W. Roberts, Judith C. Madden and Mark T.D. Cronin

In this article, we outline work that led the QSAR and Molecular Modelling Group at Liverpool John Moores University to be jointly awarded the 2013 Lush Science Prize. Our research focuses around the development of in silico profilers for category formation within the Adverse Outcome Pathway paradigm. The development of a well-defined chemical category allows toxicity to be predicted via read-across. This is the central approach used by the OECD QSAR Toolbox. The specific work for which we were awarded the Lush Prize was for the development of such an in silico profiler for respiratory sensitisation. The profiler was developed by an analysis of the mechanistic chemistry associated with covalent bond formation in the lung. The data analysed were collated from clinical reports of occupational asthma in humans. The impact of the development of in silico profilers on the Three Rs is also discussed.
You need to register (for free) to download this article. Please log in/register here.

A Normal and Biotransforming Model of the Human Bronchial Epithelium for the Toxicity Testing of Aerosols and Solubilised Substances

Zoë C. Prytherch and Kelly A. BéruBé

In this article, we provide an overview of the experimental workflow by the Lung and Particle Research Group at Cardiff University, that led to the development of the two in vitro lung models — the normal human bronchial epithelium (NHBE) model and the lung–liver model, Metabo-Lung™. This work was jointly awarded the 2013 Lush Science Prize. The NHBE model is a three-dimensional, in vitro, human tissue-based model of the normal human bronchial epithelium, and Metabo-Lung involves the co-culture of the NHBE model with primary human hepatocytes, thus permitting the biotransformation of inhaled toxicants in an in vivo-like manner. Both models can be used as alternative test systems that could replace the use of animals in research and development for safety and toxicity testing in a variety of industries (e.g. the pharmaceutical, environmental, cosmetics, and food industries). Metabo-Lung itself is a unique tool for the in vitro detection of toxins produced by reactive metabolites. This 21st century animal replacement model could yield representative in vitro predictions for in vivo toxicity. This advancement in in vitro toxicology relies on filter-well technology that will enable a wide-spectrum of researchers to create viable and economic alternatives for respiratory safety assessment and disease-focused research.
You need to register (for free) to download this article. Please log in/register here.

A Campaign to End Animal Testing: Introducing the PETA International Science Consortium Ltd

Gilly Stoddart and Jeffrey Brown

The successful development and validation of non-animal techniques, or the analysis of existing data to satisfy regulatory requirements, provide no guarantee that this information will be used in place of animal experiments. In order to advocate for the replacement of animal-based testing requirements, the PETA International Science Consortium Ltd (PISC) liaises with industry, regulatory and research agencies to establish and promote clear paths to validation and regulatory use of non-animal techniques. PISC and its members use an approach that identifies, promotes and verifies the implementation of good scientific practices in place of testing on animals. Examples of how PISC and its members have applied this approach to minimise the use of animals for the Registration, Evaluation, Authorisation and Restriction of Chemicals regulation in the EU and testing of cosmetics on animals in India, are described.
You need to register (for free) to download this article. Please log in/register here.

2013 Lush Science Prize Background Paper

Rob Harrison

The annual Lush Science Prize is designed to reward outstanding contributions to 21st Century Toxicology Research. A Background Paper is prepared each year prior to the judging process, in order to provide the judging panel with a brief overview of current developments in the field of Replacement alternatives, particularly those relevant to the concept of toxicity pathways. The Background Paper includes information on some key institutional developments in the area — such as the OECD’s Adverse Outcome Pathway Project, the Hamner Institute’s work, and the Human Toxome Project, and on the phenomenon of collaborative computer systems relevant to the field. From the literature review that was also performed as part of the background research, the two papers receiving the highest score were recommended for consideration by the judges for the 2013 Science Prize.
You need to register (for free) to download this article. Please log in/register here.